Dialysis-Clinic Integration Recovery Leader — Renal Care

The mandate

Twelve acquired clinics joined the network before their treatment-slot rules, water-system maintenance, consumable buffers, transport handoffs and clinical escalation interfaces were understood. Nominal chair capacity hides missed sessions, long changeovers and machine holds. The integration executive resigned after a regional shortage exposed incompatible emergency-transfer rules and uncertain ownership of several vulnerable patient journeys.

The interim starts within twelve days for fourteen months, holding network operating authority through stabilisation, three clinic waves and one high-demand season. The first sixty days establish treatment-and-asset truth without disrupting prescribed care. Permanent recruitment begins after wave two; the successor receives eight weeks of paired network command, three adverse simulations and one independent clinic transfer.

Handover requires capacity by treatment type, scheduling and escalation standards, verified water and machine readiness, consumable policies, transport clocks, patient-contact ownership, clinical-to-operating handoffs and reconciled acquisition actions. Completion is proven when the successor manages simultaneous clinic closure and consumable delay while preserving prescribed treatment, safe transfer, accurate family communication and regulatory evidence without interim help.

The leader may rebalance non-clinical capacity, transport and consumables, suspend an operationally unsafe clinic or machine pending authorised review, change service rosters, replace integration leads and release SAR145 million within the approved programme. Treatment prescription, clinical prioritisation, product release, permanent employment action and capital above delegation require clinical or board approval. Licensed professionals retain patient decisions.

Clinical protocols, physician credentialing, reimbursement strategy, diagnosis, pharmacy practice, new-clinic construction and enterprise health-record replacement are excluded. The interim cannot alter prescriptions, pressure clinical clearance, use unverified water systems, move patients without accepted handoff or count cancelled sessions as productivity. Patient need and consent cannot be subordinated to acquisition synergy targets.

Why this seat is open

The former integration executive left after a shortage revealed that clinic-level capacity reports omitted clinical mix and critical operating dependencies. Temporary network authority is needed because treatment continuity cannot wait for permanent recruitment or a slower integration programme.

What you will own

• Reconcile all treatment demand, chairs, machines, water, staff, consumables, transport and clinical escalation by clinic.
• Decide safe operating capacity and patient-transfer logistics inside prescribed-care and licensed clinical boundaries.
• Sequence three clinic waves around verified readiness, patient communication, asset assurance and local capability.
• Establish water, machine and consumable gates with evidence, accountable owner, intervention threshold and fallback.
• Integrate scheduling, transport, clinical escalation and family communication across acquired and retained centres.
• Command five scenarios covering water failure, product delay, machine loss, transport outage and clinic closure.
• Transfer authority after the successor completes one independent clinic wave and compound continuity event.

Candidate qualifications

• Held multi-site dialysis, ambulatory-care or comparable recurring-treatment operations authority across regulated clinics nationally at scale.
• Integrated acquired clinical sites while preserving prescribed treatment continuity, informed consent and licensed decision boundaries.
• Planned capacity using patient mix, machine readiness, water systems, staffing and consumable constraints.
• Managed emergency transfer, transport and family communication for vulnerable recurring-care populations.
• Reconciled acquisition actions with clinic-level evidence, quality requirements and accountable clinical ownership.
• Handed network command through live clinic transfer and a compound treatment-continuity simulation independently successfully.

Non-negotiables

• Available within twelve days for Riyadh residence, eighteen clinics and five simulations.
• Direct recurring-treatment clinic operations is required; hospital administration alone is insufficient.
• Will disclose providers, suppliers, transport firms, payers, investors and clinical-advisory interests.
• Will not prescribe, credential clinicians, release products, pressure clearance or override patient consent.

1. 49 words maximum. Describe a dialysis capacity report that failed because treatment or asset mix was omitted.
2. 49 words maximum. How did you preserve clinical authority during an urgent multi-site patient transfer?
3. 49 words maximum. State your Riyadh availability and the largest recurring-care network you led.